Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB) Sellers Declined Their Shorts By 9.29%

May 16, 2018 - By Pearl Odom

AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) Corporate Logo

Change of 9.29% for Ampliphi Biosciences Corporation (NYSEAMERICAN:APHB)’s short interest was reported. FINRA published in May APHB’s total 930,000 short interest. That’s 9.29% down from 1.03M shares. Former APHB’s position will need 5 days to restore. It has 181,600 average volume.

The stock decreased 6.32% or $0.0748 during the last trading session, touching $1.109.AmpliPhi Biosciences Corporation has volume of 230,337 shares. Since May 16, 2017 APHB has declined 77.34% and is downtrending. APHB underperformed the S&P 500 by 88.89%.

AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage technology.The company has $18.26 million market cap. It is also developing targeted and personalized bacteriophage therapies for patients with serious or life-threatening antibiotic-resistant infections.Last it reported negative earnings. The firm has reported results from two Phase I clinical trials of AB-SA01 for the treatment of Staphylococcus aureus in chronic rhinosinusitis patients, as well as evaluating the safety of AB-SA01 when administered topically to the intact skin of healthy adults.

AmpliPhi Biosciences Corporation (NYSEAMERICAN:APHB) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: